Hyperglycaemia in people with diabetes and chronic kidney disease

Q4 Medicine

Ugeskrift for laeger Pub Date : 2024-05-13 DOI:10.61409/v01240051

J. M. Brøsen, Tobias Bomholt, Rikke Borg, Frederik Persson, U. Pedersen-Bjergaard

引用次数: 0

Abstract

Assessment and treatment of hyperglycaemia in people with diabetes and chronic kidney disease (CKD) are challenging. In advanced CKD HbA1c can be unreliable, and treatment adjustments should be supported by other glucose measurements (e.g., continuous glucose monitoring (CGM) or blood glucose measurements). Glucose-lowering treatments should be evaluated based on CKD and an individualised assessment of risk factors especially hypoglycaemia. This review aims at providing an overview of the options for glycaemic monitoring and glucose-lowering treatments in people with diabetes and CKD.

查看原文本刊更多论文

糖尿病和慢性肾病患者的高血糖症

评估和治疗糖尿病合并慢性肾脏病（CKD）患者的高血糖具有挑战性。晚期 CKD 患者的 HbA1c 可能并不可靠，因此应通过其他血糖测量方法（如连续血糖监测 (CGM) 或血糖测量）来支持治疗调整。应根据慢性肾脏病和对风险因素（尤其是低血糖）的个体化评估来评估降糖治疗。本综述旨在概述糖尿病合并 CKD 患者的血糖监测和降糖治疗方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ugeskrift for laeger Medicine-Medicine (all)

CiteScore

0.20

自引率

0.00%

发文量

345

期刊介绍： The Ulster Medical Journal is an international general medical journal with contributions on all areas of medical and surgical specialties relevant to a general medical readership. It retains a focus on material relevant to the health of the Northern Ireland population. The Honorary Editor would welcome offers of papers for publication. Prospective authors are invited to read the notice to contributors.